Akebia Therapeutics (AKBA) Net Equity Issued and Repurchased (2013 - 2016)

Akebia Therapeutics (AKBA) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $2.2 million in Q3 2016.

• On a quarterly basis, Net Equity Issued and Repurchased fell 84.51% year-over-year to $2.2 million in Q3 2016; TTM through Sep 2016 was $16.5 million, a 355.0% increase from a year earlier, with the FY2017 full-year figure at $373.1 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased for Q3 2016 stood at $2.2 million, down from $14.2 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for AKBA reached as high as $105.8 million in Q1 2014 and fell as low as -$10.7 million in Q3 2014.
• Historically, Net Equity Issued and Repurchased has averaged $14.8 million across 4 years, with a median of $1.1 million in 2015.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 233.18% in 2015 and fell as far as 99.95% in 2015.
• Year by year, Net Equity Issued and Repurchased stood at -$2.5 million in 2013, then jumped by 101.4% to $35000.0 in 2014, then soared by 40471.43% to $14.2 million in 2015, then plunged by 84.51% to $2.2 million in 2016.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $2.2 million in Q3 2016, $14.2 million in Q3 2015, and $50000.0 in Q1 2015.